HF
ANAB icon

HRT Financial’s AnaptysBio ANAB Stock Holding History

HRT Financial’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,500
Closed -$2.54M – 3733
2025
Q4 		$2.54M Buy
+52,500
New +$2.05M 0.01% 1143

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HRT Financial's ANAB Position: Q1 2026 in Review

HRT Financial reduced its AnaptysBio (ANAB) stake by 42% in Q1 2026, selling an estimated $1.59M and leaving 40,504 shares worth $2.25M. The position accounts for 0.01% of the portfolio, ranked #1542.

HRT Financial first reported a position in ANAB in Q2 2020 and has held it in 13 quarters since. The position peaked at $3.4M in Q4 2025. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • HRT Financial held 40,504 shares of AnaptysBio worth $2.25M as of Q1 2026.
  • HRT Financial sold 29,626 AnaptysBio shares in Q1 2026, an estimated $1.59M.
  • AnaptysBio made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1542 holding.
  • HRT Financial first reported a position in AnaptysBio in Q2 2020 and has held it in 13 quarters since.
  • HRT Financial's AnaptysBio position peaked at $3.4M in Q4 2025.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.